A major advance in cancer investigation is occurring with the use of nanobodies to restore mutated p53. This essential cancer inhibitor protein is frequently disabled in several forms of malignancies, causing https://growthbookmarks.com/story21908900/vhh-fragments-reactivate-tumor-suppressor-p53-a-new-pathway-for-malignant-management